IDiyas

For the Inventor, By the Inventor

Lyme, CT, United States of America

James W McFarland

USPTO Granted Patents = 12

Average Co-Inventor Count = 1.8

ph-index = 4

Forward Citations = 51(Granted Patents)


Company Filing History:

goldMedal12 out of 4,455 
 
Pfizer Corporation
 patents

Years Active: 1976-1996

Loading Chart...
12 patents (USPTO):Explore Patents
1. 5545624 - Derivatives of 16-membered ring antibiotic macrolides (1996-08-13),
2. 5506235 - Quinoline derivatives as immunostimulants (1996-04-09),
3. 4797486 - Heterocyclic ring fused pyrimidine-4(3H)-ones as anticoccidial agents (1989-01-10),
4. 4725599 - Heterocyclic ring fused pyrimidine-4 (3H)-ones as anticoccidial agents (1988-02-16),
5. 4009160 - Aminomethylarylmethylpenicillin derivatives (1977-02-22),
6. 4002636 - Certain novel substituted tetrahydro-oxothiazolo-triazolium compounds (1977-01-11),
7. 3997527 - Aminomethylarylmethylpenicillin derivatives (1976-12-14),
8. 3966710 - Aminomethylarylmethylpenicillin derivatives (1976-06-29),
9. 3948911 - Substituted quinoxaline-2-carboxamide 1,4-dioxides (1976-04-06),
10. 3939174 - Certain 3-oxo-2-aryl-5,6-dihydro-4(H)-pyrrolo-(1,2-C)(1,2,3)triazolium (1976-02-17),
11. 3933843 - Certain 1-substituted-4-oxo-3-substituted phenyl-1,2,3-triazolium (1976-01-20),
12. 3931174 - Alkylmercaptomethylquinoxaline-1,4-dioxides and oxidized derivatives (1976-01-06),

Title: The Innovations of James W. McFarland

Introduction

James W. McFarland is a notable inventor based in Lyme, Connecticut. He has made significant contributions to the field of pharmaceuticals, holding a total of 12 patents. His work primarily focuses on antibiotic macrolides and immunostimulants, showcasing his expertise in medicinal chemistry.

Latest Patents

Among his latest patents are "Derivatives of 16-membered ring antibiotic macrolides" and "Quinoline derivatives as immunostimulants." These innovations reflect his commitment to advancing medical science and improving therapeutic options for patients.

Career Highlights

James W. McFarland is currently employed at Pfizer Corporation, a leading global pharmaceutical company. His role at Pfizer allows him to collaborate with other talented professionals in the industry, further enhancing his contributions to innovative drug development.

Collaborations

Throughout his career, McFarland has worked alongside esteemed colleagues such as Colin Thomson and Marwan J. Abu-El-Haj. These collaborations have played a crucial role in the success of his projects and the advancement of their shared goals in pharmaceutical research.

Conclusion

James W. McFarland's work exemplifies the impact of innovation in the pharmaceutical industry. His patents and collaborations continue to contribute to the development of new therapies that can benefit countless individuals.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…